Welcome!

News Feed Item

Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325412

NEW YORK, March 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325412
http://www.reportlinker.com/p02017106/Pharmaceuticals-and-Drug-Manufacturing-Industry-US-Analytics-Extensive-Financial-Benchmarks-Metrics-and-Revenue-Forecasts-to-2020-NAIC-325412.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325412

Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research.

Core Benefits to Customer:
1) Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package
2) Complete benchmarking of the industry and its top companies
3) Deep industry and company financials

This Plunkett Analytics Report Features:
1) Historical data
2) Revenue forecasts, growth rates and CAGR
3) Operating ratios
4) Complete data for benchmarking a company to its industry and to specific leading companies
5) Benchmarking this industry to all U.S. industries
6) Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies

Pages: 74
Statistical Tables Provided: 33
Charts Provided: 21
Geographic: US

Designed to benefit:
• Analysis and Financial Modeling
• Investment Professionals
• Lenders
• M&A Advisors
• Appraisers
• Consultants

Similar reports are available from Plunkett Research for nearly all U.S. industries.

"Plunkett Research has built a solid reputation providing industry analysis and research in a diverse spectrum of areas—energy and utilities, finance and investment, health care and biotechnology, and engineering and research to name a few." American Reference Books Annual

Key Data:

Industry Summary
• Revenues historical through 2013
• Revenues projected through 2020
• Employee Count 2007-2013
• Annual Growth Rate 2013
• CAGR 2005 through 2013
• CAGR 2013 through 2020
• Top U.S. Companies


Employment and Establishments
• Number of Firms 2007-2013
• Number of Establishments 2007-2013
• Employees, 2007-2013
• Average Annual Sales per Firm & per Establishment 2007-2013
• Sales per Employee

Average Annual Operating Ratios
• Revenue Compared to All Industries
• Expenses Compared to All Industries
• Profits & Income Taxes Compared to All Industries

Benchmarks

This Industry Compared to All Industries

• Comparison of Revenues, Profits and Taxes to All Industries

Industry Results, Publicly-Held Companies (U.S.), Average for all Companies
• Industry Income Statement, Balance Sheet, Cash Flow Statement, 2007-2012

Top Companies Profiled & Ranked
In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations

Top Companies Ranked
• Market Capitalization 2014
• Employees
• Revenue
• Net Income
• 3-Year Revenue Growth
• 3-Year Income Growth
• Return on Assets
• Return on Equity
• Return on Invested Capital

List of Leading (Public and Private) Companies

Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2012
• Income Statements. Balance Sheets and Cash Flow Statements


Companies Profiled:
• Johnson & Johnson
• Pfizer Inc
• Merck & Co Inc
• Abbott Laboratories
• Eli Lilly & Company
• Bristol-Myers Squibb Co
• Amgen Inc
• Genentech Inc
• Gilead Sciences Inc GILD
• Mylan Inc

Introduction
Core Benefits to Customer:
• Comprehensive overview of an industry's financial results, ratios, vital metrics in one package
• Benchmarking of:
• a) deep financials of each of the leading companies
• b) financial averages for all companies
• c) this industry's ratios to all other industries
• Historical revenues, enterprises and sales per employee
• Current and forecast revenues and CAGR to 2020
• Profiles of leading companies

Industry Description for this NAIC Code
• Types of business activities

Industry Summary, Current Data
• Revenues 2013
• Revenue forecast to 2020 with CAGR
• Historical revenues and CAGR
• CAGR, historic, through 2013
• Top U.S. companies, by revenues
• Employment, 2013 and historic

Employment and Establishments
• Number of firms and establishments, 2007-2013
• Employees, 2007-2013, with growth rates
• Average annual sales per firm & per establishment, 2007-2013
• Annual sales per employee, 2007-2013

Industry Financial Data, U.S., With Revenue Projections to 2020

Revenues, Historical and Projected
• Historical revenues & annual growth rates, 2005-2012
• Projected revenues & annual growth rates, 2013-2020

Average Annual Operating Ratio Estimates, Current
• Income items, expenses, profits and taxes as a percent of total revenues for this industry compared to all industries

Benchmarks

This Industry Compared to All Industries, Current
• Comparison of revenues for all U.S. companies within this industry to all industries
• Comparison of EBITDA, profits & income taxes for all companies within this industry to all industries

Companies Used in Creating This Study
Alphabetical list of leading companies, with details

Industry Results, Publicly-Held Companies
• Income statement averages, 2007-2012
• All income statement items, including, cost of sales, SGA, R&D, salaries and wages, EBITDA, with ratios
• Chart showing key expenses as a percent of revenues
• Balance sheet averages, 2007-2012
• All items, including property plant and equipment, accumulated depreciation, goodwill, long term debt, including ratios
• Cash flow averages, 2007-2012
• All cash flow items

Top Companies Profiled & Ranked
In-depth profiles, financial reports, ranks & executive lists for up to 10 top U.S.-based corporations

Top Companies Ranked
Company ranks:
• Approximate market capitalization 2014
• Employees
• Revenues
• Net income
• 3-Year revenue growth (%)
• 3-Year income growth (%)
• Return on assets (%)
• Return on equity (%)
• Return on invested capital (%)

Comparison of Top Publicly-Held Companies to Industry Averages, 2012
• Income statements, balance sheets and cash flow statements for each of the top companies compared to the overall industry average

Top Companies, Profiles and Financials
• Contact information, executive lists
• Business descriptions
• Key financial data for 6 years
• Brands and divisions
• Top salaries
• Corporate culture
• Charts comparing revenues vs. net income

Appendix: Assumptions
• U.S. GDP Growth and Forecasts, 2011-2020
• U.S. Total National Health Care Expenditures & Annual Percent Change and Forecast, 2012-2020
• U.S. Prescription Drugs Expenditures & Annual Percent Change and Forecast, 2012-2020

Data Description and Sources

Companies Mentioned

• Johnson & Johnson
• Pfizer Inc
• Merck & Co Inc
• Abbott Laboratories
• Eli Lilly & Company
• Bristol-Myers Squibb Co
• Amgen Inc
• Genentech Inc
• Gilead Sciences Inc GILD
• Mylan Inc

To order this report: Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325412
http://www.reportlinker.com/p02017106/Pharmaceuticals-and-Drug-Manufacturing-Industry-US-Analytics-Extensive-Financial-Benchmarks-Metrics-and-Revenue-Forecasts-to-2020-NAIC-325412.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
The now mainstream platform changes stemming from the first Internet boom brought many changes but didn’t really change the basic relationship between servers and the applications running on them. In fact, that was sort of the point. In his session at 18th Cloud Expo, Gordon Haff, senior cloud strategy marketing and evangelism manager at Red Hat, will discuss how today’s workloads require a new model and a new platform for development and execution. The platform must handle a wide range of rec...
The technologies behind big data and cloud computing are converging quickly, offering businesses new capabilities for fast, easy, wide-ranging access to data. However, to capitalize on the cost-efficiencies and time-to-value opportunities of analytics in the cloud, big data and cloud technologies must be integrated and managed properly. Pythian's Director of Big Data and Data Science, Danil Zburivsky will explore: The main technology components and best practices being deployed to take advantage...
Bill Schmarzo, Tech Chair of "Big Data | Analytics" of upcoming CloudEXPO | DXWorldEXPO New York (November 12-13, 2018, New York City) today announced the outline and schedule of the track. "The track has been designed in experience/degree order," said Schmarzo. "So, that folks who attend the entire track can leave the conference with some of the skills necessary to get their work done when they get back to their offices. It actually ties back to some work that I'm doing at the University of ...
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
Enterprises are universally struggling to understand where the new tools and methodologies of DevOps fit into their organizations, and are universally making the same mistakes. These mistakes are not unavoidable, and in fact, avoiding them gifts an organization with sustained competitive advantage, just like it did for Japanese Manufacturing Post WWII.
More and more companies are looking to microservices as an architectural pattern for breaking apart applications into more manageable pieces so that agile teams can deliver new features quicker and more effectively. What this pattern has done more than anything to date is spark organizational transformations, setting the foundation for future application development. In practice, however, there are a number of considerations to make that go beyond simply “build, ship, and run,” which changes how...
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time t...
DevOps with IBMz? You heard right. Maybe you're wondering what a developer can do to speed up the entire development cycle--coding, testing, source code management, and deployment-? In this session you will learn about how to integrate z application assets into a DevOps pipeline using familiar tools like Jenkins and UrbanCode Deploy, plus z/OSMF workflows, all of which can increase deployment speeds while simultaneously improving reliability. You will also learn how to provision mainframe syste...
CloudEXPO New York 2018, colocated with DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform and how we integrate our thinking to solve complicated problems. In his session at 19th Cloud Expo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and sh...
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term.
What are the new priorities for the connected business? First: businesses need to think differently about the types of connections they will need to make – these span well beyond the traditional app to app into more modern forms of integration including SaaS integrations, mobile integrations, APIs, device integration and Big Data integration. It’s important these are unified together vs. doing them all piecemeal. Second, these types of connections need to be simple to design, adapt and configure...
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...